Researchers have been excited about the medication , a novel dual compound showing significant outcomes in early trials for body reduction . It acts by targeting several systems: GLP-1 and GIP, which , https://ellawxtz220800.ssnblog.com/39471066/this-new-hope-for-weight-loss